Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy

Marissa LoCastro, Chandrika Sanapala, Jason H Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi D Klepin, Erin Watson, Jane Liesveld, Eric Huselton, Kristen O'Dwyer, Andrea Baran, Marie Flannery, Benzi Kluger, Kah Poh Loh, Marissa LoCastro, Chandrika Sanapala, Jason H Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi D Klepin, Erin Watson, Jane Liesveld, Eric Huselton, Kristen O'Dwyer, Andrea Baran, Marie Flannery, Benzi Kluger, Kah Poh Loh

Abstract

Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) experience intense inpatient health care at the end-of-life stage. Early advance care planning may improve care at the end of life for patients with AML or MDS. The Serious Illness Care Program (SICP) is a multicomponent, communication intervention developed to improve conversations about values for patients with serious illnesses. The SICP has been shown to improve the quality and frequency of advance care planning discussions. We adapted the SICP for delivery via telehealth to older patients with AML or MDS. We conducted a single-center qualitative study of 45 participants (25 clinicians, 15 older patients with AML or MDS, and 5 caregivers). Participants, whether clinicians, patients, or caregivers, agreed that the SICP would help older patients with AML or MDS to share their personal values with their care team. Four qualitative themes emerged from our data: (1) serious illness conversations can be conducted via telehealth, (2) older patients have limited experience using technology but are willing and able to learn, (3) patients feel that serious illness conversations will help them understand their AML or MDS diagnosis and prognosis better, and (4) serious illness conversations should be common and routine, not extraordinary. The adapted SICP may provide older patients with AML or MDS an opportunity to share what matters most to them with their care team and may assist oncologists in aligning patient care with patient values. The adapted SICP is the subject of an ongoing single-arm pilot study at the Wilmot Cancer Institute (clinicaltrials.gov identifier: NCT04745676).

Conflict of interest statement

Conflict-of-interest disclosure: K.P.L. has served as a consultant to Pfizer and Seattle Genetics and has received honoraria from Pfizer. The remaining authors declare no competing financial interests.

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Figures

Graphical abstract
Graphical abstract
Figure 1.
Figure 1.
Adapted patient preparation letter. (A) Page 1. (B) Page 2.
Figure 1.
Figure 1.
Adapted patient preparation letter. (A) Page 1. (B) Page 2.
Figure 2.
Figure 2.
Adapted SICG. (A) Page 1. (B) Page 2.
Figure 2.
Figure 2.
Adapted SICG. (A) Page 1. (B) Page 2.

References

    1. Verhoef MJ, de Nijs EJM, Ootjers CS, et al. End-of-life trajectories of patients with hematological malignancies and patients with advanced solid tumors visiting the emergency department: the need for a proactive integrated care approach. Am J Hosp Palliat Care. 2020;37(9):692–700.
    1. Fletcher SA, Cronin AM, Zeidan AM, et al. Intensity of end-of-life care for patients with myelodysplastic syndromes: findings from a large national database. Cancer. 2016;122(8):1209–1215.
    1. LoCastro M, Baran AM, Liesveld JL, et al. Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes. Blood Adv. 2021;5(24):5554–5564.
    1. Alibhai SM, Leach M, Minden MD, Brandwein J. Outcomes and quality of care in acute myeloid leukemia over 40 years. Cancer. 2009;115(13):2903–2911.
    1. Dangi-Garimella S. QOPI, the ASCO initiative, improves compliance and promotes quality of patient care. Am J Manag Care. 2014;20(5 Spec No.):SP153–SP155.
    1. Cheng HW, Li CW, Chan KY, et al. End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia. Support Care Cancer. 2015;23(1):111–116.
    1. Wang R, Zeidan AM, Halene S, et al. Health care use by older adults with acute myeloid leukemia at the end of life. J Clin Oncol. 2017;35(30):3417–3424.
    1. Sudore RL, Lum HD, You JJ, et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage. 2017;53(5):821–832.e821.
    1. Agarwal R, Epstein AS. Advance care planning and end-of-life decision making for patients with cancer. Semin Oncol Nurs. 2018;34(3):316–326.
    1. Smith A. Should we shift from advanced care planning to serious illness communication? Podcast. 24 February 2022.
    1. Bernacki R, Hutchings M, Vick J, et al. Development of the Serious Illness Care Program: a randomised controlled trial of a palliative care communication intervention. BMJ Open. 2015;5(10):e009032.
    1. Bernacki R, Paladino J, Neville BA, et al. Effect of the Serious Illness Care Program in outpatient oncology: a cluster randomized clinical trial. JAMA Intern Med. 2019;179(6):751–759.
    1. Bories P, Lamy S, Simand C, et al. Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey. Haematologica. 2018;103(12):2040–2048.
    1. Abdallah M, Xie Z, Ready A, Manogna D, Mendler JH, Loh KP. Management of acute myeloid leukemia (AML) in older patients. Curr Oncol Rep. 2020;22(10):103.
    1. Bhatt VR, Shostrom V, Armitage JO, Gundabolu K. Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia. Am J Hematol. 2019;94(6):E169–E172.
    1. Klepin HD, Geiger AM, Tooze JA, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121(21):4287–4294.
    1. Saad M, Loh KP, Tooze JA, et al. Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia. Blood. 2020;136(23):2715–2719.
    1. Koonin LM, Hoots B, Tsang CA, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic - United States, January-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1595–1599.
    1. Shepherd L, Goldstein D, Whitford H, Thewes B, Brummell V, Hicks M. The utility of videoconferencing to provide innovative delivery of psychological treatment for rural cancer patients: results of a pilot study. J Pain Symptom Manage. 2006;32(5):453–461.
    1. Chumbler NR, Mkanta WN, Richardson LC, et al. Remote patient-provider communication and quality of life: empirical test of a dialogic model of cancer care. J Telemed Telecare. 2007;13(1):20–25.
    1. Kichloo A, Albosta M, Dettloff K, et al. Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Community Health. 2020;8(3)
    1. LoCastro M, Sanapala C, Mendler JH, et al. Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes. J Geriatr Oncol. 2022
    1. Heyer A, Granberg RE, Rising KL, Binder AF, Gentsch AT, Handley NR. Medical oncology professionals' perceptions of telehealth video visits. JAMA Netw Open. 2021;4(1):e2033967.
    1. Granberg RE, Heyer A, Rising KL, Handley NR, Gentsch AT, Binder AF. Medical oncology patient perceptions of telehealth video visits. JCO Oncol Pract. 2021;17(9):e1333–e1343.
    1. Ftouni R, AlJardali B, Hamdanieh M, Ftouni L, Salem N. Challenges of telemedicine during the COVID-19 pandemic: a systematic review. BMC Med Inform Decis Mak. 2022;22(1):207.
    1. Goldberg EM, Lin MP, Burke LG, Jiménez FN, Davoodi NM, Merchant RC. Perspectives on telehealth for older adults during the COVID-19 pandemic using the quadruple aim: interviews with 48 physicians. BMC Geriatr. 2022;22(1):188.
    1. Cimperman M, Brenčič MM, Trkman P, Stanonik Mde L. Older adults' perceptions of home telehealth services. Telemed J E Health. 2013;19(10):786–790.
    1. Clayton JM, Butow PN, Arnold RM, Tattersall MH. Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer. 2005;103(9):1965–1975.
    1. Butow PN, Dowsett S, Hagerty R, Tattersall MH. Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer. 2002;10(2):161–168.
    1. Repetto L, Piselli P, Raffaele M, Locatelli C. Communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study. Eur J Cancer. 2009;45(3):374–383.
    1. Fenton JJ, Duberstein PR, Kravitz RL, et al. Impact of prognostic discussions on the patient-physician relationship: prospective cohort study. J Clin Oncol. 2018;36(3):225–230.
    1. Karim S, Levine O, Simon J. The Serious Illness Care Program in oncology: evidence, real-world implementation and ongoing barriers. Curr Oncol. 2022;29(3):1527–1536.
    1. Karim S, Lupichuk S, Tan A, Sinnarajah A, Simon J. Real world implementation of the Serious Illness Care Program in cancer care: results of a quality improvement initiative. J Palliat Med. 2021;24(6):905–909.
    1. Kumar P, Wixon-Genack J, Kavanagh J, Sanders JJ, Paladino J, O'Connor NR. Serious illness conversations with outpatient oncology clinicians: understanding the patient experience. JCO Oncol Pract. 2020;16(12):e1507–e1515.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel